Contemporary Data on Treating Multiple Sclerosis Exacerbations

The director of the Kansas City Multiple Sclerosis Center at College Park Neurology, discusses goals of therapy in patients with relapsing multiple sclerosis, especially for the subset of patients in which steroids are not an option or are ineffective.

Jeffrey M. Kaplan, MD, discusses therapy goals for relapsing multiple sclerosis and highlights treatment options.

Neurologist Matthew J. Baker, MD, describes the relationship between gut microbiota and risk of relapse in patients with multiple sclerosis.

Drs Jeffrey M. Kaplan and Matthew J. Baker consider repository corticotropin injection as a treatment option for patients with relapsing multiple sclerosis based on data recently presented during ACTRIMS 2020.

An overview of data revealed at ACTRIMS 2020 regarding the relationship between incomplete recovery from multiple sclerosis attacks in the first 3 years and 10-year disability.

The rationale behind an ongoing study assessing the response rate, safety, and tolerability of repository corticotropin injection in patients with relapsing-remitting multiple sclerosis who have an inadequate response to high-dose steroids.
SAP Partner Banner